Envoy Medical Earnings Date & Estimates

Envoy Medical (NASDAQ:COCHW) is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technologies are designed to use the body’s natural anatomy to capture sound and deliver auditory stimulation, with the goal of providing hearing restoration without the external components required by many conventional hearing devices.

Envoy Medical’s lead product is the Acclaim cochlear implant, a fully implanted device intended for adults with sensorineural hearing loss who may benefit from cochlear implantation. Unlike traditional cochlear implants, the Acclaim system is designed to be implanted beneath the skin and uses the natural eardrum and middle-ear structures to detect sound. The company has also developed the Esteem active middle-ear implant, an earlier fully implanted hearing device designed to address sensorineural hearing loss.

Founded in 1995 and based in Minnesota, Envoy Medical has focused its research and product development on implantable hearing solutions for the global hearing-health market. Its products and technologies have been subject to regulatory development and clinical evaluation, with commercialization dependent on applicable approvals in the United States and other markets. The company is led by Chief Executive Officer Brent Lucas.